PCOS Treatment Market to Witness Significant Growth until 2025
Rising obesity among women
population to drive the growth of global PCOS treatment market
According
to TechSci Research report, “Global PCOS
Treatment Market By Treatment (Surgeries v/s Drug Treatment), By Diagnosis
(Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals &
Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast
& Opportunities, 2025”, the global PCOS treatment market is expected to grow at a formidable
rate during the forecast period on account of the rising awareness pertaining
to diseases and reproductive health among the population. Additionally,
initiatives taken by various government and non-government organizations for
spreading awareness and providing schemes and services for the welfare of women
is further expected to positively impact the growth of market over the next few
years. Furthermore, easy access to PCOS therapeutics, growing demand for PCOS
medication and rising popularity of combination therapy are further expected to
foster the growth of market through 2025. However, easy availability of
generics and off the label drugs might hinder the growth of market during
forecast period. Additionally, lack of approved therapeutics and side effects
of the available drugs might hamper the growth of market over the next few
years. Also, at present no targeted therapy is available for this syndrome &
it is only controlled through medication and some surgical procedures.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on" Global
PCOS Treatment Market"
https://www.techsciresearch.com/report/pcos-treatment-market/4683.html
The global PCOS treatment market is segmented based on treatment,
diagnosis, end user, company and region. Based on treatment the market can be
bifurcated into surgeries and drug treatment. The drug treatment segment can
further be categorized into oral contraceptives, antiandrogens,
anti-depressants, insulin-sensitizing agents, anti-obesity drugs, others. The
insulin-sensitizing agents segment is expected to dominate the market since
they lower the insulin levels in blood and help in maintaining hormonal
balance. The surgeries segment is further bifurcated into ovarian wedge resection and laparoscopic
ovarian drilling. The ovarian wedge resection segment is expected to witness
significant growth during the forecast years as this method removes some part
of the ovary, which helps in regulating menstrual cycle and promotes ovulation.
Bristol-Myers Squibb Company, Bayer
AG, Pfizer, Inc., Abbott Laboratories, Merck & Co., Inc., Sanofi SA, AstraZeneca
Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring
Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., EffRx Pharmaceuticals SA, Mylan
N.V., Millendo Therapeutics, Inc. and others are some of the leading
players operating in global PCOS treatment market. The companies
operating in the market are using organic strategies such as product launches,
mergers and collaborations to boost their share. For instance, in January 2106,
AstraZeneca announced that they have started start up for women health
treatment and invested USD62 million in drug development for poly cystic
ovarian disorder.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4683
Customers can also request for 10% free customization on
this report.
“North America is expected to dominate
the global PCOS treatment market during the forecast period, owing to the presence
of well-developed healthcare infrastructure in the region. Additionally, availability
of skilled medical personnel coupled with large PCOS patient pool in the region
is further expected to create lucrative opportunities for the market players over
the next few years. Furthermore, better reimbursement policies in the region
are encouraging the population for PCOS treatment and surgeries, thereby anticipated
to drive the growth of market over the next few years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Global PCOS Treatment Market By Treatment
(Surgeries v/s Drug Treatment), By Diagnosis (Pelvic Examination, Ultrasound,
Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical
Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025”,” has evaluated the future growth potential of global PCOS
treatment market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global PCOS treatment market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]